Condition: Dry Skin · Sensitive Skin · Dry Skin in the Elderly · Sponsor: Centre de Pharmacologie Clinique Applique a la Dermatologie
This clinical study aims to determine whether taking two different doses of collagen-derived peptides for three months improves facial skin barrier integrity in women with dry, sensitive skin, compared with a placebo.
This description comes directly from the study's public registry record.
Anne-Claire Cathelineau · 04 92 03 62 40 · cpcad@skinpharma.fr
Always discuss trial participation with your own doctor first.
| CPCAD - Centre Pharmacologie Clinique Appliqué à la Dermatologie, CHU Nice | Nice, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07529249